Christine Cameron

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

M. Caligiuri, M. Ross, R. Soiffer, 1993, The Journal of clinical investigation.

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.

J. Ritz, R. Soiffer, J. Daley, 1992, Blood.

Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.

M. Atkins, J. Ritz, M. Lotze, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.

M. Caligiuri, R. Soiffer, M. Seiden, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.

R. Soiffer, L. Nadler, J. Daley, 1993, Blood.